| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 11 |
| 1 | EVEROLIMUS | 4 |
| 2 | LUTETIUM LU 177 DOTATATE | 4 |
| 3 | PANITUMUMAB | 4 |
| 4 | EVEROLIMUS TABLETS | 3 |
| 5 | FLUOROURACIL | 3 |
| 6 | FLUOROURACIL CREAM, 0.5% | 3 |
| 7 | HYDROMORPHONE HYDROCHLORIDE | 3 |
| 8 | DEXAMETHASONE | 2 |
| 9 | DEXAMETHASONE 1.5 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUTETIUM LU 177 DOTATATE | 4 | 0.0007 |
| 1 | PANITUMUMAB | 4 | 0.0002 |
| 2 | MIFEPRISTONE | 1 | 0.0002 |
| 3 | EVEROLIMUS TABLETS | 3 | 0.0002 |
| 4 | HYDROXYUREA | 2 | 0.0001 |
| 5 | BEVACIZUMAB | 11 | 0.0001 |
| 6 | EVEROLIMUS | 4 | 0.0001 |
| 7 | IRINOTECAN HYDROCHLORIDE | 1 | 0.0001 |
| 8 | OCTREOTIDE ACETATE | 2 | 0.0001 |
| 9 | LACOSAMIDE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 1 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 2 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 4 | 0.0001 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 11 | 0.0001 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |
| 6 | Androgen Receptor Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Estrogen [EPC] | 1 | 0.0000 |